ARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell Therapies

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 08 Oct, 18:37 UTC

Cell therapies and other biologics depend on ultracold storage and tightly controlled shipping. ARPA-H has funded teams of companies, research agencies, and universities developing alternatives, aiming to widen patient access to these therapies. The post ARPA-H’s BoSS Program Funds Three Teams…

science

Sources

• T2ARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell TherapiesFierce Biotech / Fierce Healthcare / MedCity / GEN08 Oct, 18:37